Blue Barn Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Sell |
4,843
-271
| -5% | -$18.7K | 0.16% | 95 |
|
|
2025
Q1 | $355K | Sell |
5,114
-1,495
| -23% | -$104K | 0.19% | 84 |
|
|
2024
Q4 | $569K | Buy |
6,609
+51
| +0.8% | +$4.39K | 0.3% | 55 |
|
|
2024
Q3 | $781K | Buy |
6,558
+123
| +2% | +$14.6K | 0.4% | 45 |
|
|
2024
Q2 | $919K | Buy |
6,435
+29
| +0.5% | +$4.14K | 0.51% | 37 |
|
|
2024
Q1 | $823K | Sell |
6,406
-299
| -4% | -$38.4K | 0.46% | 39 |
|
|
2023
Q4 | $694K | Sell |
6,705
-35
| -0.5% | -$3.62K | 0.41% | 39 |
|
|
2023
Q3 | $613K | Buy |
6,740
+1,338
| +25% | +$122K | 0.4% | 42 |
|
|
2023
Q2 | $437K | Sell |
5,402
-164
| -3% | -$13.3K | 0.28% | 60 |
|
|
2023
Q1 | $443K | Sell |
5,566
-118
| -2% | -$9.39K | 0.27% | 66 |
|
|
2022
Q4 | $385K | Buy |
5,684
+1,308
| +30% | +$88.5K | 0.25% | 65 |
|
|
2022
Q3 | $218K | Buy |
4,376
+406
| +10% | +$20.2K | 0.16% | 104 |
|
|
2022
Q2 | $221K | Sell |
3,970
-622
| -14% | -$34.6K | 0.17% | 100 |
|
|
2022
Q1 | $255K | Buy |
4,592
+202
| +5% | +$11.2K | 0.18% | 91 |
|
|
2021
Q4 | $246K | Buy |
4,390
+18
| +0.4% | +$1.01K | 0.17% | 97 |
|
|
2021
Q3 | $210K | Buy |
+4,372
| New | +$210K | 0.18% | 103 |
|